Former Tecan CEO joins CUTISS as the company strengthens its Board for the next phase of growth. Switzerland, 23 June 2026 – CUTISS, a late-stage clinical company at the forefront of tissue therapeutics and regenerative medicine, has announced the election of Dr. Achim von Leoprechting as Chairman of its Board of Directors.